The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

Glenmark Pharmaceuticals receives UK approval for Winlevi, a groundbreaking topical acne treatment with unique mechanism of ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

The pact is the latest in a string of agreements signed in recent years that will contribute to a significant upsurge in local pharmaceutical manufacturing capacity in Oman ...

The UK currently has some additional reporting ... As such, observational research provides an important means for pharma companies to assess the effectiveness and proper use of medicinal products ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

As Donald Trump wields the threat of tariffs on EU and even UK goods, which industries would be worst affected and could the ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

The five-year voluntary pricing deal between pharma companies and the U.K. Department of Health is under severe pressure after the rebate the industry is due to pay leapt from 15.3% in 2024 to 22.9% ...